Dow Corning will address the need to accelerate product development, reduce time to market and create value at this year’s CPhI Worldwide from 7-9 October 2014 in Paris, France. At Stand #5R31, visitors can discover a broad range of new products and high performance silicones for pharmaceutical and consumer healthcare applications including topical ingredients, topical excipients, transdermal adhesives and oral Active Pharmaceutical Ingredients (APIs). Dow Corning experts will be on hand to share their knowledge acquired through decades of formulation, regulatory and cGMP production experience.
Myriam Delvaux, Global Marketing Leader Drug Delivery Systems: “CPhI is the premier Expo and networking event of the year and the perfect forum for Dow Corning to reinforce our experience and leadership for the use of silicon-based materials serving the entire spectrum of the pharmaceutical industry from consumer chosen healthcare to physician prescribed Rx applications. This year is particularly exciting, as it will see the launch of Dow Corning® Topical Ingredients – our latest innovation for consumer healthcare topical formulations with new silicon-based ingredients. These can help to develop unique solutions in a range of product forms and will be featured at the Innovation Gallery in Hall 5A, Stand G21.”
Also on show will be a broad array of silicone ingredients for Dow Corning® Topical Pharmaceutical Excipients for Prescription/RX Topical Drug Delivery Systems. These solutions can help customers improve efficacy and compliance of topical treatments using a range of versatile silicone excipients.
Furthermore, the specialty chemical company will showcase its large range of Dow Corning® BIO-PSA adhesives designed to adhere drug loaded systems to the skin for transdermal drug delivery applications. Compatible with a wide range of drugs, excipients and skin penetration enhancers, Dow Corning BIO-PSA’s can be formulated to provide various drug release rate profiles of drug.